Loading provider…
Loading provider…
Hematology & Oncology Physician in Oklahoma City, OK
NPI: 1679542963Primary Practice Location
O U MEDICAL CENTER
1200 N Childrens Ave, Oklahoma City, OK
Primary Employer
OU Health Partners
ouhealth.com
HQ Phone
Get MD George's Phone NumberMobile
Get MD George's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOK State Medical License
Incidence and risk factors for graft failure in the modern era of cord blood transplantation.
DMSO induced myocardial infarction during allogeneic cryopreserved bone marrow transplant.
Authors: Amrita Krishnan, Christopher Bredeson, Christopher Dandoy, Mark Juckett
Journal: Biol Blood Marrow Transplant
Publication Date: 2018-01-31
Lead Sponsor: PrECOG, LLC.
Collaborators: Astellas Pharma Inc
Intervention / Treatment: DRUG: Midostaurin, DRUG: Cytarabine, DRUG: Daunorubicin, DRUG: Gilteritinib
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, BIOLOGICAL: Pegfilgrastim, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, DRUG: Dacarbazine, DRUG: Brentuximab Vedotin, PROCEDURE: Computed Tomography, BIOLOGICAL: Filgrastim, DRUG: Vinblastine Sulfate, DRUG: Doxorubicin Hydrochloride
Lead Sponsor: Center for International Blood and Marrow Transplant Research
Collaborators: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Medical College of Wisconsin, Blood and Marrow Transplant Clinical Trials Network, National Marrow Donor Program
Intervention / Treatment: OTHER: Donor Search Prognosis Score